Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
07/01/2004 | US20040127496 Imidazole-2-carboxamide derivatives as raf kinase inhibitors |
07/01/2004 | US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome |
07/01/2004 | US20040127484 Novel bicyclic inhibitors of hormone sensitive lipase |
07/01/2004 | US20040127477 Heterocyclic glycyl beta-alanine derivatives |
07/01/2004 | DE10260879A1 Mittel zum Färben von keratinhaltigen Fasern Formulations for coloring keratin-containing fibers |
07/01/2004 | DE10260730A1 Neue substituierte stickstoffhaltige Heterobicyclen, deren Herstellung und deren Verwendung als Arzneimittel New substituted nitrogen containing heterobicycles, their preparation and their use as medicaments |
07/01/2004 | DE10259407A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis |
07/01/2004 | CA2549463A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands |
07/01/2004 | CA2510683A1 Carbazole derivatives and their use as npy-5 antagonists |
07/01/2004 | CA2510323A1 4-anilino quinazoline derivatives for the treatment of abnormal cell growth |
07/01/2004 | CA2509244A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
07/01/2004 | CA2509239A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
07/01/2004 | CA2509233A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
07/01/2004 | CA2509214A1 Indolizine compounds |
07/01/2004 | CA2509104A1 5-aminophenanthridine derivatives as npy-5 antagonists |
07/01/2004 | CA2507425A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists |
06/30/2004 | EP1433840A1 Composition and method for bleaching a substrate |
06/30/2004 | EP1433788A1 Pyrazole-derivatives as factor Xa inhibitors |
06/30/2004 | EP1433786A1 Benzoxazole compound and pharmaceutical composition containing the compound |
06/30/2004 | EP1433785A1 Agents for the coloration of keratinous fibres |
06/30/2004 | EP1433783A2 Naphthalenecarboxamides as tachykinin receptor antagonists |
06/30/2004 | EP1433781A1 Pyrrolidine carboxylic acid derivatives |
06/30/2004 | EP1433479A1 Appetite-stimulating agents and remedies for anorexia |
06/30/2004 | EP1433468A1 N-Methyl quinolinium imines used for dyeing keratin containing fibres |
06/30/2004 | EP1432734A1 Cytokine receptor |
06/30/2004 | EP1432713A2 Fused pyrimidine dhfr inhibitors as antibacterials |
06/30/2004 | EP1432706A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
06/30/2004 | EP1432701A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
06/30/2004 | EP1432700A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
06/30/2004 | EP1432699A1 Pyridylfurans and pyrroles as raf kinase inhibitors |
06/30/2004 | EP1432698A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
06/30/2004 | EP1432697A1 Pyridylfurans and pyrroles as raf kinase inhibitors |
06/30/2004 | EP1432693A2 Mch receptor antagonists |
06/30/2004 | EP1432691A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
06/30/2004 | EP1432690A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
06/30/2004 | EP1432689A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
06/30/2004 | EP1432688A1 Insecticidal and acaricidal 3-substituted pyrazoles |
06/30/2004 | EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
06/30/2004 | EP1432686A1 Tetrahydroisochinolines, their production and the use thereof as analgesics |
06/30/2004 | EP1432679A1 Preparation and use of pyrrole derivatives for treating obesity |
06/30/2004 | EP1432421A1 Quinoline derivatives as neuropeptide y antagonists |
06/30/2004 | EP1432420A2 Benzimidazolidinone derivatives as muscarinic agents |
06/30/2004 | EP1432417A2 Substituted benzimidazole compounds and their use for the treatment of cancer |
06/30/2004 | EP1432416A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
06/30/2004 | EP1432415A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
06/30/2004 | EP1432313A1 N-thio-nicotinamide derivatives and related compounds for use as pesticides |
06/30/2004 | EP1214313B1 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same |
06/30/2004 | EP1178982B1 Heterocyclic substituted aminoazacycles useful as central nervous system agents |
06/30/2004 | EP1045693B1 Aminophenoxyacetic acid derivatives as neuroprotectants |
06/30/2004 | EP1037880B1 Retinoic acid mimetic anilides |
06/30/2004 | EP0977600B1 Contrast agents targetting receptors associated with angiogenesis |
06/30/2004 | EP0809629B1 2-phenyl-substituted heterocyclic 1,3-ketonols as herbicides and pesticides |
06/30/2004 | CN1509290A Process for synthesis of derivatives of 2,30dihydro-1,4-dioxino-[2,3-f]quinoline |
06/30/2004 | CN1509286A Metalloproteinase inhibitors |
06/30/2004 | CN1509283A Novel pyridyl cyanoguandine compounds |
06/30/2004 | CN1509282A 4-(phenyl-piperdin-4-ylidene-methyl)benzamide derivatives and theive use for treating pain, anxiety or gastrointestinal disorders |
06/30/2004 | CN1509281A Benzimidazol derivatives modulate che mokine receptors |
06/30/2004 | CN1509278A N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound |
06/30/2004 | CN1509276A Metalloproteinase inhibitors |
06/30/2004 | CN1509275A Metalloproteinase inhibitors |
06/30/2004 | CN1509274A Metallo proteinase inhibitors |
06/30/2004 | CN1509273A Metalloproteinase inhibitors |
06/30/2004 | CN1509272A Metalloproteinase inhibitors |
06/30/2004 | CN1509271A 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for treatment of pain anxiety or gastrointestinal disorders |
06/30/2004 | CN1509270A Indolinons, substituted in position 6, and their preparation and use as kinase inhibitors |
06/30/2004 | CN1509184A Antipruritscs |
06/30/2004 | CN1509170A Method for inhibiting adhesion formation |
06/30/2004 | CN1509140A Pyridinyl fused bicyclic amide as fungicides |
06/30/2004 | CN1508129A Method for synthesizing pyrrole amides |
06/30/2004 | CN1155596C New phenylpiperazines |
06/30/2004 | CN1155595C Substituted pyrroles as antiproliferative agents for treatment of cancer |
06/30/2004 | CN1155572C Indole derivatives and its anticancer usage |
06/30/2004 | CN1155570C Novel cyano-indole serotonin reextracted inhibitor compound, its preparation process and medicinal compositions having same |
06/29/2004 | US6756498 Process for the preparation of chemical compounds |
06/29/2004 | US6756397 Such as (s)-n-(2-((1-chloromethyl)-1,2-dihydro-5-((4-methylpiperazino)carbonyloxy) -3h-benz(e) indol-3-yl)carbonyl)-1h-indol-5-yl)-5-((3-methyldithio-1-oxopropyl)-amino) -1h-indole-2-carboxamide; enhanced water solubility and stability |
06/29/2004 | US6756393 Amides and ureas n-substituted with piperidine or nortropane; serotonin inverse agonists or antagonists; antipsychotic |
06/29/2004 | US6756391 Antiviral compounds |
06/29/2004 | US6756387 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
06/29/2004 | US6756386 Such as 1-methyl-3-oxy-(5-chloro-3-pyridyl)-piperidine; cholinergic system of central nervous system; pain, inflammation |
06/29/2004 | US6756385 Imidazole derivatives |
06/29/2004 | US6756380 5-phenyl-pyrimidine derivatives |
06/29/2004 | US6756378 VLA-4 inhibitor compounds |
06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
06/29/2004 | US6756370 Piperidine alcohols |
06/29/2004 | US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
06/29/2004 | US6756023 Having heat exchange circuit passed through; cocurrent operation without pump system design modifications |
06/29/2004 | US6755875 Piperidine-n-oxy group containing compounds stabilizes white, dyed, dipped, unscented or scented candle wax against discolration and fading |
06/29/2004 | CA2207404C Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase |
06/29/2004 | CA2205384C Dihydropyrimidines and uses thereof |
06/29/2004 | CA2161256C Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole |
06/24/2004 | WO2004052995A1 Process for the production of meso-substituted cyanine dyes |
06/24/2004 | WO2004052890A1 Heterocyclic compounds, methods of making them and their use in therapy |
06/24/2004 | WO2004052884A1 Anthranilic acid amide derivatives and their pharmaceutical use |
06/24/2004 | WO2004052882A1 Process for preparing optically pure active compounds |
06/24/2004 | WO2004052881A2 Process for preparing (s)-pantoprazole |
06/24/2004 | WO2004052880A1 Pyridine derivatives as jnk inhibitors and their use |
06/24/2004 | WO2004052868A1 Pyrazine-based tubulin inhibitors |
06/24/2004 | WO2004052864A1 Pyrazole and imidazole compounds and uses thereof |
06/24/2004 | WO2004052862A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
06/24/2004 | WO2004052861A1 Hydroxyalkylated cyclic diamine compound |